Breaking News Instant updates and real-time market news.

2022-01-20 15:08:05 EDNMY Edenred $23.26 / +0.06 (+0.26%) 15:08 01/20/22 01/20 15:08 01/20/22 15:08	Edenred price target lowered to EUR 51.50 from EUR 53.50 at Deutsche Bank Deutsche Bank analyst Andre Juillard lowered the firm's price target on Edenred to EUR 51.50 from EUR 53.50 and keeps a Buy rating on the shares.

2022-01-20 15:08:05

EDNMY

Edenred

$23.26 / +0.06 (+0.26%)

15:08

01/20/22

01/20

15:08

01/20/22

15:08

Edenred price target lowered to EUR 51.50 from EUR 53.50 at Deutsche Bank

Deutsche Bank analyst Andre Juillard lowered the firm's price target on Edenred to EUR 51.50 from EUR 53.50 and keeps a Buy rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Downgrade	Abercrombie & Fitch downgraded to Neutral from Buy at Citi » 07:36 05/23/22 05/23 07:36 05/23/22 07:36 ANF Abercrombie & Fitch $27.99 / -1.075 (-3.70%) Citi analyst Paul Lejuez… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ANF Abercrombie & Fitch $27.99 / -1.075 (-3.70%) 03/31/22 Netflix teases trailer for documentary on 'rise and fall' of Abercrombie & Fitch 03/16/22 Abercrombie & Fitch launches new activewear sub-brand YPB 03/02/22 Abercrombie & Fitch falls -16.8% 03/02/22 Abercrombie & Fitch falls -15.6% ANF Abercrombie & Fitch $27.99 / -1.075 (-3.70%) 05/16/22 JPMorgan Abercrombie & Fitch price target raised to $39 from $35 at JPMorgan 04/11/22 JPMorgan Abercrombie & Fitch price target lowered to $35 from $41 at JPMorgan 03/16/22 B. Riley B. Riley says teen/young adult apparel 'poised for a breakout' 03/03/22 B. Riley Abercrombie & Fitch price target lowered to $48 from $54 at B. Riley ANF Abercrombie & Fitch $27.99 / -1.075 (-3.70%) 03/02/22 Abercrombie & Fitch sees 2022 net sales up 2%-4% vs. 2021 03/02/22 Abercrombie & Fitch sees Q1 net sales up low-single-digits vs. last year 03/02/22 Abercrombie & Fitch reports Q4 adjusted EPS $1.14, consensus $1.27 03/01/22 Notable companies reporting before tomorrow's open ANF Abercrombie & Fitch $27.99 / -1.075 (-3.70%) 03/02/22 What You Missed On Wall Street On Wednesday 03/02/22 Fly Intel: Pre-market Movers 01/10/22 Fly Intel: After-Hours Movers 11/23/21 Wall Street in Fives - Must Read Lists at Midday 05/24/22 Abercrombie & Fitch - ANF 06/08/22 Abercrombie & Fitch Co.
Hot Stocks	Osisko Development to commence trading on New York Stock Exchange » 07:35 05/23/22 05/23 07:35 05/23/22 07:35 RNGTF Osisko Development $3.26 / + (+0.00%) , ODV Osisko Development / + Osisko Development is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research RNGTF RNGTF Osisko Development $3.26 / + (+0.00%) 05/04/22 Osisko Development announces completion of share consolidation 04/27/22 Osisko Development announces results from annual, special meeting 04/13/22 Osisko Development announces drilling results from Cariboo project 02/28/22 Osisko Development announces drilling results from San Antonio project RNGTF ODV RNGTF Osisko Development $3.26 / + (+0.00%) 03/04/22 Desjardins Osisko Development price target lowered to C$7.50 from C$8 at Desjardins 02/04/22 Desjardins Osisko Development price target lowered to C$8 from C$8.25 at Desjardins 01/11/22 RBC Capital Osisko Development initiated with an Outperform at RBC Capital 09/10/21 National Bank Osisko Development price target lowered to C$9.50 from C$10.25 at National Bank ODV Osisko Development / +
Syndicate	Reynolds Consumer Products files automatic mixed securities shelf 07:35 05/23/22 05/23 07:35 05/23/22 07:35 REYN Reynolds Consumer Products $26.78 / -0.08 (-0.30%) ShowHide Related Items >><< Street Research Earnings On The Fly REYN Reynolds Consumer Products $26.78 / -0.08 (-0.30%) 04/13/22 Stifel Reynolds Consumer Products downgraded to Hold at Stifel on higher input costs 04/13/22 Stifel Reynolds Consumer Products downgraded to Hold from Buy at Stifel 03/30/22 JPMorgan Reynolds Consumer Products price target lowered to $33 from $34 at JPMorgan 03/29/22 Goldman Sachs Reynolds Consumer Products downgraded to Sell from Buy at Goldman Sachs REYN Reynolds Consumer Products $26.78 / -0.08 (-0.30%) 05/10/22 Reynolds Consumer Products sees Q2 EPS 23c-27c, consensus 39c 05/10/22 Reynolds Consumer Products reports Q1 EPS 26c, consensus 26c 02/09/22 Reynolds Consumer Products sees FY22 adjusted EPS $1.56-$1.70, consensus $1.73 02/09/22 Reynolds Consumer Products sees Q1 adjusted EPS 24c-28c, consensus 30c REYN Reynolds Consumer Products $26.78 / -0.08 (-0.30%) 05/10/22 What You Missed On Wall Street On Tuesday 05/10/22 What You Missed On Wall Street This Morning 04/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/29/22 What You Missed On Wall Street On Tuesday
Hot Stocks	WisdomTree announces agreement with Fireblocks in relation to WisdomTree Prime » 07:35 05/23/22 05/23 07:35 05/23/22 07:35 WETF WisdomTree $5.63 / +0.075 (+1.35%) WisdomTree Investments… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings WETF WisdomTree $5.63 / +0.075 (+1.35%) 05/05/22 WisdomTree responds to 'false, misleading' assertions made by ETFS, Lion Point 04/29/22 WisdomTree COO expects to be 'first mover in digital assets' 04/20/22 WisdomTree says Say platform live for Q1 earnings 04/20/22 WisdomTree announces New Economy Real Estate Fund WETF WisdomTree $5.63 / +0.075 (+1.35%) 04/08/22 Morgan Stanley WisdomTree price target lowered to $6.75 from $7 at Morgan Stanley 04/07/22 Deutsche Bank WisdomTree price target lowered to $6 from $7 at Deutsche Bank 11/01/21 Deutsche Bank WisdomTree price target raised to $7 from $6 at Deutsche Bank 08/01/21 Keefe Bruyette WisdomTree upgraded to Outperform from Market Perform at Keefe Bruyette WETF WisdomTree $5.63 / +0.075 (+1.35%) 04/29/22 WisdomTree reports Q1 adjusted EPS 9c, consensus 8c 01/28/22 WisdomTree reports Q4 adjusted EPS 10c, consensus 9c
Hot Stocks	MindMed names Schond Greenway as CFO » 07:34 05/23/22 05/23 07:34 05/23/22 07:34 MNMD MindMed / + , AVTX Avalo Therapeutics / + Mind Medicine (MNMD)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MNMD AVTX MNMD MindMed / + 05/19/22 MindMed reports data from Phase 1 trial of MM-110 05/11/22 MindMed collaborators announce positive topline data of LSD in anxiety disorders 04/05/22 MindMed names Francois Lilienthal, MD as Chief Commercial Officer 03/25/22 MindMed CFO David Guebert to retire on March 31 AVTX Avalo Therapeutics / + 05/18/22 Avalo Therapeutics announces first patient dosed in Phase 2 PEAK trial 03/02/22 Avalo Therapeutics ends 2021 with $56.4M in cash, cash equivalents 02/17/22 Avalo Therapeutics appoints Garry Neil as CEO, Chris Sullivan as CFO 01/10/22 Avalo Therapeutics names Stephen Smolinski as Chief Commercial Officer MNMD AVTX MNMD MindMed / + 05/04/22 Roth Capital MindMed initiated with a Buy at Roth Capital 08/18/21 Canaccord MindMed price target lowered to C$4.25 from C$5 at Canaccord 08/05/21 H.C. Wainwright MindMed initiated with a Buy at H.C. Wainwright 06/28/21 Maxim MindMed initiated with a Buy, $6 price target at Maxim AVTX Avalo Therapeutics / + 03/03/22 Jefferies Avalo Therapeutics cut to Hold at Jefferies after pipeline reprioritization 03/03/22 Jefferies Avalo Therapeutics downgraded to Hold from Buy at Jefferies 09/24/21 RBC Capital Avalo Therapeutics initiated with an Outperform at RBC Capital AVTX AVTX Avalo Therapeutics / + 05/05/22 Avalo Therapeutics reports Q1 EPS (20c) vs (32c) last year 15 Sep AVTX AVTX Avalo Therapeutics / + 01/19/22 COVID-19 treatment developed by Avalo 'passes' phase 2 trial, researchers say MNMD MNMD MindMed / + 05/04/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/25/22 Wall Street in Fives - Must Read Lists for Tuesday 01/25/22 Wall Street in Fives - Must Read Lists at Midday 06/01/22 Mind Medicine Inc 06/14/22 Avalo Therapeutics Inc MNMD MNMD MindMed / + 05/18/22 Largest borrow rate increases among liquid names 03/28/22 MindMed options imply 4.9% move in share price post-earnings 02/15/22 Largest borrow rate increases among liquid names

Hot Stocks	Worlds NFT offering to feature David Bowie's BowieWorld » 07:33 05/23/22 05/23 07:33 05/23/22 07:33 WDDD Worlds Inc. / + Worlds announces that its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News WDDD Worlds Inc. / + 04/11/22 Worlds Inc. partners with CrossTower for NFT marketplace services 03/11/22 U.S. Court of Appeals upholds invalidity ruling on Worlds Inc. patents 03/09/22 U.S. Court of Appeals hears World's oral argument on 3D virutal worlds patents 01/24/22 Oral argument for Worlds Inc. appeal in Activision case set for March 8
Hot Stocks	ShockWave, Genesis obtain regulatory approval in China for Shockwave IVL System » 07:33 05/23/22 05/23 07:33 05/23/22 07:33 SWAV ShockWave Medical $158.27 / -1.78 (-1.11%) Shockwave Medical and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events SWAV ShockWave Medical $158.27 / -1.78 (-1.11%) 05/19/22 ShockWave Medical announces long-term data from Disrupt PAD III trial 05/19/22 ShockWave announces data on one-year outcomes with coronary IVL 03/31/22 ShockWave announces launch of peripheral intravascular lithotripsy catheter 03/30/22 ShockWave Medical announces Japanese regulatory approval of Coronary IVL SWAV ShockWave Medical $158.27 / -1.78 (-1.11%) 05/10/22 Canaccord ShockWave Medical price target lowered to $190 from $221 at Canaccord 05/10/22 Wells Fargo ShockWave Medical price target lowered to $176 from $235 at Wells Fargo 05/10/22 Piper Sandler ShockWave pullback an opportunity after 'strong' Q1, says Piper Sandler 04/05/22 Wolfe Research ShockWave Medical initiated with an Outperform at Wolfe Research SWAV ShockWave Medical $158.27 / -1.78 (-1.11%) 05/09/22 ShockWave Medical raises FY22 revenue view to $435M-$455M from $405-$425M 05/09/22 ShockWave Medical reports Q1 EPS 39c, consensus 18c 02/17/22 ShockWave Medical sees FY22 revenue$405M-$425M, consensus $386.73M 02/17/22 ShockWave Medical reports Q4 EPS 34c, consensus 8c SWAV ShockWave Medical $158.27 / -1.78 (-1.11%) 01/18/22 ShockWave loses bid to revive patents for artery-clearing system, Bloomberg says 01/07/22 ShockWave Medical mulls potential deal after receiving interest, Bloomberg says SWAV ShockWave Medical $158.27 / -1.78 (-1.11%) 05/10/22 Fly Intel: Pre-market Movers 02/17/22 Fly Intel: After-Hours Movers 01/10/22 Wall Street in Fives - Must Read Lists for Monday 01/10/22 Wall Street in Fives - Must Read Lists at Midday 05/31/22 2022 Wells Fargo West Coast MedTech Tour 09/07/22 2022 Wells Fargo Healthcare Conference 08/08/22 ShockWave Medical - SWAV 06/23/22 ShockWave Medical, Inc.
Hot Stocks	Camping World to acquire Richardson's RV Centers » 07:33 05/23/22 05/23 07:33 05/23/22 07:33 CWH Camping World $26.08 / -0.93 (-3.44%) Camping World announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options CWH Camping World $26.08 / -0.93 (-3.44%) 05/19/22 Camping World director buys $284K in common stock 02/22/22 Camping World boosts regular quarterly dividend by 25% 02/17/22 Camping World to acquire Bowling RVs in Iowa 02/16/22 Camping World announces cybersecurity incident CWH Camping World $26.08 / -0.93 (-3.44%) 05/05/22 Baird Camping World price target lowered to $35 from $40 at Baird 05/04/22 Raymond James Camping World price target lowered to $40 from $45 at Raymond James 04/13/22 DA Davidson Camping World initiated with a Neutral at DA Davidson 03/02/22 Truist Camping World cut to Hold at Truist on more cautious stance toward RV space CWH Camping World $26.08 / -0.93 (-3.44%) 05/03/22 Camping World reports Q1 EPS $1.15, consensus $1.38 02/22/22 Camping World reports Q4 adjusted EPS 90c, consensus 84c CWH Camping World $26.08 / -0.93 (-3.44%) 05/08/22 Short Report: GitLab back in bears’ crosshairs 04/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/04/22 Short Report: Robinhood, Big Lots short interest at record high 02/05/22 Short Report: GitLab short position re-accelerates to record high CWH Camping World $26.08 / -0.93 (-3.44%) 05/19/22 Camping World put volume heavy and directionally bearish 05/19/22 Unusually active option classes on open May 19th 05/06/22 Camping World call volume above normal and directionally bullish 05/03/22 Camping World options imply 11.3% move in share price post-earnings
Hot Stocks	Soligenix granted U.S. patent for thermostabilized vaccine platform » 07:32 05/23/22 05/23 07:32 05/23/22 07:32 SNGX Soligenix / + Soligenix has been issued… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SNGX Soligenix / + 03/17/22 Soligenix's COVID-19 vaccine boosts neutralizing activity in non-human primates 01/04/22 Soligenix announces new studies supporting effectiveness of dusquetide 12/02/21 Soligenix's single vial vaccine shows 100% protection against Sudan ebolavirus SNGX Soligenix / + 08/25/21 Alliance Global Partners Soligenix price target lowered to $3.75 from $5.75 at Alliance Global Partners 06/01/21 B. Riley Soligenix price target lowered to $1.50 from $2 at B. Riley
Recommendations	Latch workforce redaction a net positive, says William Blair » 07:32 05/23/22 05/23 07:32 05/23/22 07:32 LTCH Latch $2.20 / -0.005 (-0.23%) William Blair analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options LTCH Latch $2.20 / -0.005 (-0.23%) 05/20/22 Latch announces reset of cost structure 03/29/22 Latch CFO Mitchell to resign, appoint Schaeffer as interim CFO, Nakamura as CAO LTCH Latch $2.20 / -0.005 (-0.23%) 02/28/22 Imperial Capital Latch downgraded to In-Line from Outperform at Imperial Capital 02/28/22 Baird Latch price target lowered to $4 from $8 at Baird 02/25/22 Cantor Fitzgerald Latch downgraded to Neutral from Overweight at Cantor Fitzgerald 02/14/22 Keefe Bruyette Latch initiated with a Market Perform at Keefe Bruyette LTCH Latch $2.20 / -0.005 (-0.23%) 05/05/22 Latch Sees FY22 revenue $75M-$100M, consensus $86.62M. 05/05/22 Latch sees Q2 revenue $16.5M-$18.5M, consensus $18.06M 05/05/22 Latch reports Q1 EPS (31c), consensus (32c) 02/24/22 Latch reports Q4 net loss 53,908 vs. 19,193 loss in Q420 LTCH Latch $2.20 / -0.005 (-0.23%) 02/25/22 What You Missed On Wall Street On Friday 02/25/22 What You Missed On Wall Street This Morning 06/09/22 Latch Inc LTCH Latch $2.20 / -0.005 (-0.23%) 02/24/22 Latch options imply 16.2% move in share price post-earnings

Hot Stocks	Biohaven Pharmaceutical: FDA accepts for review NDA for zavegepant nasal spray » 07:32 05/23/22 05/23 07:32 05/23/22 07:32 BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) Biohaven Pharmaceutical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 07:19 Today Biohaven Pharmaceutical provides update on Phase 3 troriluzole trial in SCA 05/10/22 Biohaven Pharmaceutical rises 70.2% 05/10/22 Biohaven Pharmaceutical rises 70.8% 05/10/22 Biohaven Pharmaceutical rises 70.7% BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/11/22 H.C. Wainwright Biohaven Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright 05/11/22 Wedbush Global Blood Therapeutics added to Best Ideas List at Wedbush 05/02/22 Piper Sandler Piper sees 'outright misinformation' on Biohaven, says buy shares 04/22/22 Piper Sandler Biohaven widening lead over AbbVie in migraine, says Piper Sandler BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/10/22 Biohaven Pharmaceutical sees 2022 net product sales $825M-$900M 05/10/22 Biohaven Pharmaceutical reports Q1 EPS ($2.97), consensus ($2.53) 02/25/22 Biohaven Pharmaceutical reports Q4 adjusted EPS ($2.32), consensus ($2.04) BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 01/13/22 Biogen working with Goldman to explore possible acquisitions, STAT says BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/10/22 What You Missed On Wall Street On Tuesday 05/10/22 What You Missed On Wall Street This Morning 05/10/22 Fly Intel: Pre-market Movers 01/13/22 Wall Street in Fives - Must Read Lists for Thursday
Hot Stocks	Immunocore and Medison Pharma extend multi-territorial agreement for Kimmtrak » 07:29 05/23/22 05/23 07:29 05/23/22 07:29 IMCR Immunocore $30.25 / +1.13 (+3.88%) Immunocore announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings IMCR Immunocore $30.25 / +1.13 (+3.88%) 04/04/22 Immunocore announces EC approval of KIMMTRAK 02/25/22 Immunocore announces CHMP opinion recommending approval of Kimmtrak 01/26/22 Immunocore announces FDA approval of KIMMTRAK 12/06/21 Immunocore announces initial Phase 1 data from IMC-C103C IMCR Immunocore $30.25 / +1.13 (+3.88%) 02/08/22 H.C. Wainwright Immunocore initiated with a Buy at H.C. Wainwright 11/11/21 JPMorgan Immunocore share catalysts are 'picking up,' says JPMorgan 10/19/21 Oppenheimer Immunocore initiated with an Outperform at Oppenheimer IMCR Immunocore $30.25 / +1.13 (+3.88%) 05/11/22 Immunocore reports Q1 EPS EUR 37 vs. EUR 76 last year 03/03/22 Immunocore reports Q4 EPS ($1.21), three estimates (1.10)
Initiation	Applied Blockchain initiated with a Buy at Craig-Hallum » 07:28 05/23/22 05/23 07:28 05/23/22 07:28 APLD Applied Blockchain / + Craig-Hallum analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events APLD Applied Blockchain / + 05/10/22 Applied Blockchain expands blockchain industry infrastructure 04/13/22 Applied Blockchain prices $40M initial public offering APLD Applied Blockchain / + 05/09/22 Lake Street Applied Blockchain initiated with a Buy at Lake Street 05/09/22 Northland Applied Blockchain initiated with an Outperform at Northland 05/09/22 B. Riley Applied Blockchain initiated with a Buy at B. Riley 05/09/22 Needham Applied Blockchain initiated with a Buy at Needham 13 Apr APLD Applied Blockchain / + 05/09/22 What You Missed On Wall Street On Monday 05/09/22 What You Missed On Wall Street This Morning 05/09/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/07/22 Opening Day: Bausch + Lomb pops in public debut 05/25/22 22nd Annual Institutional Investor Conference
Upgrade	Wesdome Gold Mines upgraded to Buy from Hold at Canaccord » 07:28 05/23/22 05/23 07:28 05/23/22 07:28 WDOFF Wesdome Gold Mines $9.56 / +0.114 (+1.21%) Canaccord analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research WDOFF Wesdome Gold Mines $9.56 / +0.114 (+1.21%) 05/05/22 Wesdome Gold Mines announces drilling results from Eagle River Mine 04/14/22 Wesdome Gold Mines reports Q1 gold production of 25,611 oz 02/08/22 Wesdome Gold Mines announces results from Kiena Deep A Zone 01/13/22 Wesdome Gold Mines sees 2022 production 160,000-180,000 ounces WDOFF Wesdome Gold Mines $9.56 / +0.114 (+1.21%) 05/12/22 TD Securities Wesdome Gold Mines price target lowered to C$19 from C$20 at TD Securities 04/20/22 National Bank Wesdome Gold Mines price target raised to C$19 from C$18.75 at National Bank 04/07/22 RBC Capital Wesdome Gold Mines initiated with a Sector Perform at RBC Capital 03/14/22 TD Securities Wesdome Gold Mines price target raised to C$17.50 from C$15.50 at TD Securities
Upgrade	Kainos Group upgraded to Buy from Hold at Canaccord » 07:27 05/23/22 05/23 07:27 05/23/22 07:27 KNNNF Kainos Group $25.55 / + (+0.00%) Canaccord analyst Kai… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KNNNF Kainos Group $25.55 / + (+0.00%) 05/16/22 Berenberg Kainos Group downgraded to Hold from Buy at Berenberg 11/15/21 Canaccord Kainos Group price target raised to 1,880 GBp from 1,765 GBp at Canaccord

Upgrade	Argonaut Gold upgraded to Hold from Sell at Canaccord » 07:27 05/23/22 05/23 07:27 05/23/22 07:27 ARNGF Argonaut Gold $1.13 / +0.09522 (+9.20%) Canaccord analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ARNGF Argonaut Gold $1.13 / +0.09522 (+9.20%) 05/16/22 Desjardins Argonaut Gold price target lowered to C$2.50 from C$3.25 at Desjardins 05/12/22 Scotiabank Argonaut Gold price target lowered to C$3 from C$3.50 at Scotiabank 05/12/22 Canaccord Argonaut Gold downgraded to Sell from Hold at Canaccord 04/19/22 Scotiabank Argonaut Gold price target raised to C$3.50 from C$3.25 at Scotiabank
Recommendations	Deal for VMware would be synergistic with Broadcom strategy, says BofA » 07:23 05/23/22 05/23 07:23 05/23/22 07:23 AVGO Broadcom $544.19 / -1.72 (-0.32%) , VMW VMware $95.71 / +0.76 (+0.80%) BofA analyst Vivek Arya… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AVGO VMW AVGO Broadcom $544.19 / -1.72 (-0.32%) 05/22/22 Fly Intel: Top five weekend stock stories 05/06/22 TD Synnex secures cybersecurity aggregator agreement with Broadcom 05/03/22 Broadcom announces opportunities for solutions with Z16 Mainframe 04/24/22 Fly Intel: Top five weekend stock stories VMW VMware $95.71 / +0.76 (+0.80%) 05/22/22 Fly Intel: Top five weekend stock stories 05/04/22 VMware, Wipro expand partnership for customers' digital transformation 04/06/22 VMware and Deloitte to launch strategic Distributed Cloud Practice 04/05/22 VMware CFO sells $3.9M in common stock AVGO VMW AVGO Broadcom $544.19 / -1.72 (-0.32%) 06:13 Today Piper Sandler VMware passes Broadcom deal 'smell-test,' says Piper Sandler 05/20/22 Daiwa Daiwa sees six month 'danger zone' for semiconductor stocks 05/17/22 Piper Sandler Piper moves to 'more positive stance' on semiconductor stocks 04/14/22 Credit Suisse TSMC results may give 'tactical reprieve' to U.S. Semis, says Credit Suisse VMW VMware $95.71 / +0.76 (+0.80%) 06:13 Today Piper Sandler VMware passes Broadcom deal 'smell-test,' says Piper Sandler 05/18/22 Mizuho VMware price target lowered to $115 from $125 at Mizuho 02/25/22 Barclays VMware price target lowered to $135 from $140 at Barclays 02/25/22 Oppenheimer VMware price target lowered to $135 from $148 at Oppenheimer AVGO VMW AVGO Broadcom $544.19 / -1.72 (-0.32%) 03/03/22 Broadcom sees Q2 revenue $7.9B, consensus $7.43B 03/03/22 Broadcom reports Q1 adjusted EPS $8.39, consensus $8.08 03/03/22 Notable companies reporting after market close 12/09/21 Broadcom sees Q1 revenue $7.6B, consensus $7.25B VMW VMware $95.71 / +0.76 (+0.80%) 02/24/22 VMware sees FY23 EPS $6.97, consensus $7.29 02/24/22 VMware sees Q1 EPS $1.56, consensus $1.64 02/24/22 VMware reports Q4 adjusted EPS $2.02, consensus $1.97 02/24/22 Notable companies reporting after market close AVGO VMW AVGO Broadcom $544.19 / -1.72 (-0.32%) 05/22/22 Broadcom in talks to acquire VMware, Reuters reports 04/23/22 Merck, CVS among dividend stocks to help whip inflation now, Barron's says 04/22/22 Broadcom once again in FTC crosshairs over antitrust, Information says 03/05/22 Cloud stocks have become a haven in tech, Barron's says VMW VMware $95.71 / +0.76 (+0.80%) 05/22/22 Broadcom in talks to acquire VMware, Reuters reports 04/13/22 Hackers exploiting VMware servers, Bleeping Computer says AVGO VMW AVGO Broadcom $544.19 / -1.72 (-0.32%) 03/04/22 What You Missed On Wall Street On Friday 03/04/22 What You Missed On Wall Street This Morning 03/03/22 Fly Intel: After-Hours Movers 12/27/21 Fly Insider: Hyatt, Alnylam among week's notable insider trades VMW VMware $95.71 / +0.76 (+0.80%) 02/25/22 What You Missed On Wall Street On Friday 02/25/22 What You Missed On Wall Street This Morning 02/25/22 Fly Intel: Pre-market Movers 02/24/22 Fly Intel: After-Hours Movers 05/27/22 Technology 05/26/22 VMware - VMW 06/02/22 Broadcom - AVGO AVGO VMW AVGO Broadcom $544.19 / -1.72 (-0.32%) 12/14/21 Broadcom put volume heavy and directionally bearish 12/10/21 Early notable gainers among liquid option names on December 10th 12/09/21 Broadcom options imply 3.2% move in share price post-earnings VMW VMware $95.71 / +0.76 (+0.80%) 12/02/21 VMware call volume above normal and directionally bullish 11/23/21 VMware options imply 4.8% move in share price post-earnings
Hot Stocks	Secoo receives withdrawal of Richard Rixue Li's going private proposal » 07:21 05/23/22 05/23 07:21 05/23/22 07:21 SECO Secoo Holding / + Secoo Holding announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News SECO Secoo Holding / + 04/19/22 Secoo announces changes to board composition 04/07/22 Secoo Holding, ZiWu announce NFT cooperation
Hot Stocks	Concert :THRIVE-AA1 study meets primary endpoint for scalp hair regrowth » 07:20 05/23/22 05/23 07:20 05/23/22 07:20 CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) Concert Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) 01/04/22 Concert Pharmaceuticals completes enrollment in THRIVE-AA2 trial CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) 11/12/21 JMP Securities Concert Pharmaceuticals price target lowered to $10 from $17 at JMP Securities 10/05/21 Mizuho Concert Pharmaceuticals price target lowered to $9 from $13 at Mizuho CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) 05/05/22 Concert Pharmaceuticals reports Q1 EPS ($1.03), consensus (91c) 03/03/22 Concert Pharmaceuticals reports Q4 EPS ($1.01), consensus (73c) 06/09/22 Concert Pharmaceuticals, Inc.
Hot Stocks	Jaguar Health announces launch of U.S. Canine Cancer Registry » 07:20 05/23/22 05/23 07:20 05/23/22 07:20 JAGX Jaguar Health / + Jaguar Health, announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options JAGX Jaguar Health / + 05/11/22 Jaguar Health announces launch of Mytesi telehealth program 05/03/22 Jaguar Health files for conditional new animal drug approval of Canalevia 04/27/22 Jaguar Health announces commercial availability of Canalevia-CA1 04/05/22 Jaguar Health appoints Pravin Chaturvedi as CSO, chair of SAB JAGX Jaguar Health / + 07/07/21 Fly Intel: Top five analyst initiations 07/07/21 Cantor Fitzgerald Jaguar Health initiated with an Overweight at Cantor Fitzgerald JAGX Jaguar Health / + 05/10/22 Jaguar Health reports Q1 EPS (40c) vs. (28c) last year 06/10/22 Jaguar Health Inc. JAGX Jaguar Health / + 01/14/22 Largest borrow rate increases among liquid names

Hot Stocks	Biohaven Pharmaceutical provides update on Phase 3 troriluzole trial in SCA » 07:19 05/23/22 05/23 07:19 05/23/22 07:19 BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) Biohaven Pharmaceutical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/10/22 Biohaven Pharmaceutical rises 70.2% 05/10/22 Biohaven Pharmaceutical rises 70.8% 05/10/22 Biohaven Pharmaceutical rises 70.7% 05/10/22 Pfizer to acquire Biohaven Pharmaceuticals for $148.50 per share BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/11/22 H.C. Wainwright Biohaven Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright 05/11/22 Wedbush Global Blood Therapeutics added to Best Ideas List at Wedbush 05/02/22 Piper Sandler Piper sees 'outright misinformation' on Biohaven, says buy shares 04/22/22 Piper Sandler Biohaven widening lead over AbbVie in migraine, says Piper Sandler BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/10/22 Biohaven Pharmaceutical sees 2022 net product sales $825M-$900M 05/10/22 Biohaven Pharmaceutical reports Q1 EPS ($2.97), consensus ($2.53) 02/25/22 Biohaven Pharmaceutical reports Q4 adjusted EPS ($2.32), consensus ($2.04) BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 01/13/22 Biogen working with Goldman to explore possible acquisitions, STAT says BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/10/22 What You Missed On Wall Street On Tuesday 05/10/22 What You Missed On Wall Street This Morning 05/10/22 Fly Intel: Pre-market Movers 01/13/22 Wall Street in Fives - Must Read Lists for Thursday
Hot Stocks	Kaman to acquire Parker-Hannifin aircraft wheel & brake division for $440M » 07:18 05/23/22 05/23 07:18 05/23/22 07:18 KAMN Kaman $32.87 / -0.725 (-2.16%) , PH Parker-Hannifin $258.80 / -4.05 (-1.54%) Kaman (KAMN) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly KAMN PH KAMN Kaman $32.87 / -0.725 (-2.16%) 07:06 Today Parker-Hannifin to divest Aircraft Wheel, Brake Division to Kaman 05/02/22 Kaman maintains FY guidance 04/20/22 Kaman announces $50M share repurchase program 03/07/22 Kaman gets follow-up award for HH-60W combat rescue helicopter cockpits PH Parker-Hannifin $258.80 / -4.05 (-1.54%) 07:06 Today Parker-Hannifin to divest Aircraft Wheel, Brake Division to Kaman 04/28/22 Parker-Hannifin increases quarterly cash dividend 29% to $1.33 per share 04/11/22 Parker-Hannifin says European Commission clears acquisition of Meggitt 04/05/22 Parker-Hannifin says third party gained unauthorized access to company's systems KAMN PH KAMN Kaman $32.87 / -0.725 (-2.16%) 05/04/22 KeyBanc Kaman price target lowered to $45 from $52 at KeyBanc 02/28/22 KeyBanc Kaman price target lowered to $52 from $59 at KeyBanc 06/23/21 KeyBanc Kaman price target lowered to $59 from $65 at KeyBanc PH Parker-Hannifin $258.80 / -4.05 (-1.54%) 05/06/22 Mizuho Parker-Hannifin price target lowered to $290 from $305 at Mizuho 04/18/22 Stifel Parker-Hannifin price target lowered to $338 from $384 at Stifel 04/14/22 Deutsche Bank Parker-Hannifin price target lowered to $335 from $343 at Deutsche Bank 04/04/22 Barclays Parker-Hannifin price target lowered to $350 from $376 at Barclays KAMN PH KAMN Kaman $32.87 / -0.725 (-2.16%) 05/02/22 Kaman reports Q1 adjusted EPS 15c vs. 29c last year 02/24/22 Kaman reports Q4 adjusted EPS 48c, consensus 47c PH Parker-Hannifin $258.80 / -4.05 (-1.54%) 05/05/22 Parker-Hannifin updates FY22 adjusted EPS view $18.00-$18.30 from $17.80-$18.30 05/05/22 Parker-Hannifin reports Q3 adjusted EPS $4.83, consensus $4.65 02/03/22 Parker-Hannifin raises FY22 adjusted EPS view $17.80-$18.30 from $16.95-$17.65 02/03/22 Parker-Hannifin reports Q2 adjusted EPS $4.46, consensus $3.91 PH PH Parker-Hannifin $258.80 / -4.05 (-1.54%) 04/01/22 EU regulators set to clear Parker-Hannifin's bid for Meggitt, Reuters says 04/01/22 EU antitrust regulators to approve Parker-Hannifin bid for Meggitt, Reuters says KAMN PH KAMN Kaman $32.87 / -0.725 (-2.16%) 05/02/22 Fly Intel: After-Hours Movers PH Parker-Hannifin $258.80 / -4.05 (-1.54%) 04/01/22 What You Missed On Wall Street On Friday 04/01/22 What You Missed On Wall Street This Morning
Hot Stocks	Parsons to acquire Xator Corporation in $343M transaction » 07:18 05/23/22 05/23 07:18 05/23/22 07:18 PSN Parsons $36.24 / +0.365 (+1.02%) Parsons Corporation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PSN Parsons $36.24 / +0.365 (+1.02%) 05/18/22 Parsons announces Parsons X approach 04/22/22 Parsons releases 2022 ESG report 04/13/22 Parsons completes critical design review for directed energy system 03/31/22 Parsons to highlight space domain capabilities at Space Symposium PSN Parsons $36.24 / +0.365 (+1.02%) 04/22/22 Truist Parsons downgraded to Hold from Buy at Truist 03/17/22 Stifel Parsons resumed with a Buy at Stifel 03/11/22 BofA Parsons upgraded to Neutral from Underperform at BofA 03/11/22 BofA Parsons upgraded to Neutral from Underperform at BofA PSN Parsons $36.24 / +0.365 (+1.02%) 05/04/22 Parsons backs 2022 revenue view $3.7B-$3.9B, consensus $3.8B 05/04/22 Parsons reports Q1 adjusted EPS 40c, consensus 38c 02/23/22 Parsons sees 2022 revenue $3.7B-$3.9B, consensus $3.79B 02/23/22 Parsons reports Q4 adjusted EPS 55c, consensus 53c PSN Parsons $36.24 / +0.365 (+1.02%) 03/04/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/01/22 IT Services Summit 06/14/22 Aerospace, Defense & Airlines ESG Virtual Summit 08/08/22 7th Annual Wells Fargo FinTech & Technology Services Forum
Downgrade	Athersys downgraded to Underperform from Neutral at BofA » 07:17 05/23/22 05/23 07:17 05/23/22 07:17 ATHX Athersys / + BofA analyst Greg… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options ATHX Athersys / + 05/20/22 Athersys sinks after partner's stem-cell therapy study fails to meet endpoint 04/04/22 Athersys: Healios K.K. reports update on MultiStem programs in Japan 01/20/22 Athersys appoints Daniel Camardo as CEO 11/30/21 Athersys announces peer-reviewed publication of data from MUST-ARDS trial ATHX Athersys / + 07:13 Today BofA Correction: Athersys downgraded to Underperform from Neutral at BofA 11/19/21 BofA Athersys downgraded to Neutral from Buy at BofA (yesterday) ATHX Athersys / + 05/06/22 Athersys reports Q1 EPS (9c), consensus (10c) 03/15/22 Athersys reports Q4 EPS (9c), consensus (7c) 06/15/22 Athersys, Inc. ATHX Athersys / + 03/15/22 Athersys options imply 26.0% move in share price post-earnings 12/09/21 Largest borrow rate increases among liquid names 12/08/21 Largest borrow rate increases among liquid names 12/06/21 Largest borrow rate increases among liquid names
Recommendations	Compass Minerals price target lowered to $55 from $73 at Deutsche Bank » 07:17 05/23/22 05/23 07:17 05/23/22 07:17 CMP Compass Minerals $43.37 / -0.91 (-2.06%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CMP Compass Minerals $43.37 / -0.91 (-2.06%) 05/05/22 Compass Minerals sees FY22 adjusted EBITDA $170M-$200M 04/12/22 Compass Minerals gets maximum payment from sale of specialty plant unit 04/11/22 Compass Minerals provides Q2 snow data and salt segment sales update 02/01/22 Compass Minerals to replace Great Western in S&P 600 at open on 2/1 CMP Compass Minerals $43.37 / -0.91 (-2.06%) 05/11/22 CL King Compass Minerals price target lowered to $52 from $67 at CL King 04/18/22 BMO Capital Compass Minerals price target raised to $63 from $60 at BMO Capital 03/03/22 CL King Compass Minerals price target raised to $67 from $65 at CL King 02/10/22 JPMorgan Compass Minerals downgraded to Underweight from Neutral at JPMorgan CMP Compass Minerals $43.37 / -0.91 (-2.06%) 05/05/22 Compass Minerals reports Q2 adjusted EPS 33c, consensus 91c 02/08/22 Compass Minerals cuts FY22 adjusted EBITDA view to $200M-$235M 02/08/22 Compass Minerals reports Q1 adjusted EPS 38c, consensus 55c CMP Compass Minerals $43.37 / -0.91 (-2.06%) 05/05/22 Fly Intel: After-Hours Movers

Events

Earnings calls, analyst events, roadshows and more

XPEV
Today at 08:00

XPeng - XPEV Conference Calls
NIU
Today at 08:00

Niu Technologies - NIU Conference Calls
CAAS
Today at 08:00

China Automotive - CAAS Conference Calls
JPM
Today at 08:00

JPMorgan Firm Sponsored Meetings

Virtual Meeting
CSTE
Today at 08:00

Caesarstone Firm Sponsored Meetings

Virtual Meeting
Today at 08:30

Chicago Fed National Activity Index--3 Month Moving Average: April 2022 Government Event
Today at 08:30

Chicago Fed National Activity Index: April 2022 Government Event
RSLS
Today at 08:30

ReShape Lifesciences - RSLS Conference Calls
AVPT
Today at 09:00

AvePoint Firm Sponsored Meetings

Virtual Meeting
GILT
Today at 09:30

Gilat Satellite - GILT Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Edenred price target lowered to EUR 51.50 from EUR 53.50 at Deutsche Bank

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access